Goblet cell mucous secretion pathway

The "Goblet cell mucous secretion pathway" is not a single, specific molecular target but refers to the collective cellular and molecular processes by which goblet cells secrete mucus (primarily polymeric mucins such as MUC2, MUC5AC, and MUC5B) to maintain barrier and immune functions in mucosal tissues[1][2]. Goblet cells are specialized epithelial cells primarily found in the respiratory and gastrointestinal tracts, where they synthesize, store, and secrete gel-forming mucins through regulated and baseline exocytosis pathways[5][1]. Mucin secretion can be triggered by stimuli such as acetylcholine, irritants, or microbial products, and involves tightly regulated mechanisms including vesicle fusion and expansion largely dependent on ionic changes and pH regulation[1][6]. Dysfunction or overproduction of mucus by goblet cells is implicated in diseases including asthma, infections, ulcerative colitis, and neoplasia[2][5][7]. There are no drugs that directly target the pathway as a whole, though agents influencing cholinergic signaling, inflammation, or mucin production may have indirect effects[6]. Because this is a pathway (cellular process) and not a defined molecule, receptor, enzyme, or other canonical druggable target, it should not be considered a proper "therapeutic target" in the sense of the provided schema. Key details: Goblet cell mucous secretion pathway is a process, not a specific molecule or receptor[1][2][5]. Main function: Synthesis, storage, and regulated secretion of mucins (e.g., MUC2 in the intestine, MUC5AC/MUC5B in the airway)[1][2][5]. Regulation: Involves several secretory machinery proteins (e.g., Syntaxins, Munc18, SNAREs)[1], regulated by signals such as acetylcholine[3][6]. Disease relevance: Overproduction or impaired clearance contributes to asthma, colitis, chronic infection, and other mucosal diseases[2][5][7]. Not a single druggable target: No specific drugs act exclusively on this pathway, but drugs affecting mucin production or secretion often alter disease outcomes indirectly[6]. This entry is best considered an umbrella term for a physiological process rather than an entry for a distinct drug target.

Other names

Goblet cell exocytosisGoblet cell mucus secretionMucin secretion by goblet cell